• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

CMS: Meaningful Use Payments Tops $25.7B

by Jasmine Pennic 12/11/2014 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Meaningful Use Payments_CMS Report_EHR Incentive Payments

As of December 1st, CMS has paid more than $25.7 billion in meaningful use payments to eligible hospitals and professionals, according to the latest CMS data. Elisabeth Myers, head of CMS’ Office of eHealth Standards and Services made announcement on Tuesday during a Health IT policy Committee meeting. 

MU Registation and Payment Data

CMS data reported 505,641 active participants in the meaningful use incentive program through October 2014 broken down by: 

October-14 Program To Date 
Medicare Eligible Professional 2510 335,964
Medicaid Eligible Professionals 1845 164,912 
Hospitals 18 4,765 
Totals 4,373 505,641 

2014 MU Attestation Data

2014 MU attestions through December 1, 2014 include: 

– 60561 EP successfully attested for 2014 

    – 17046 new participants 

    – 16455 Attested to Stage 2 

– 3696 Hospitals successfully attested for 2014 

   – 292 New participants 

   – 1681 Attested to Stage 2

CHIME Response to MU Stage 2 Challenges

In a response to the latest CMS data, College of Healthcare Information Management Executives (CHIME) President and CEO Russell Branzell released a statement addressing how the low meaningful use stage 2 numbers validate the need for a shortened reporting period in 2015. 

“Despite policy efforts to mitigate a disastrous program year, today’s release of participation data confirms widespread challenges with Stage 2 Meaningful Use,” said CHIME President and CEO Russell P. Branzell, FCHIME, CHCIO. “This trend demonstrates how vital new flexibilities were in 2014 and again, underscores the need for the same flexibility in 2015,” said Branzell. “It is imperative officials take immediate action to put this critical transformation program back on track. Shortening the time frame for MU reporting in 2015 will help to ensure the program delivers on its promise to advance the transformation of healthcare in this country.” 

As of December 1st, less than 35 percent of the nation’s hospitals have met Stage 2 Meaningful Use requirements.Roughly 1 in 3 hospitals scheduled to meet Stage 2 in 2014 had to use alternative pathways to meet MU, administrative data current through December 1 indicate. Only 4 percent of eligible professionals (EPs) have meet Stage 2 requirements and have until the end of February 2015 to report their progress. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Meaningful Use Payments

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |